“Clinical trials referral resource. Clinical trials using thalidomide,”, Oncology, vol. 10, pp. 1498-1501, 1996.
, “Clinical trials referral resource. Clinical trials with tomudex,”, Oncology, vol. 10, pp. 1041-2, 1996.
, “Clinical trials referral resource. Clinical trials with tomudex.”, Oncology (Williston Park), vol. 10, no. 7, pp. 1041-2, 1996.
, “Combination treatment of rheumatoid arthritis using azathioprine and methotrexate: a 48 week controlled clinical trial.”, J Rheumatol Suppl, vol. 44, pp. 64-8, 1996.
, “Comparing methods for calculating confidence intervals for vaccine efficacy.”, Stat Med, vol. 15, no. 21-22, pp. 2379-92, 1996.
, “Disease clusters in structured environments,”, Stat Med, vol. 15, pp. 851-71, 1996.
, “Disease clusters in structured environments.”, Stat Med, vol. 15, no. 7-9, pp. 851-71, 1996.
, “Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi),”, Hepatology, vol. 23, pp. 1041-6, 1996.
, “Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi).”, Hepatology, vol. 23, no. 5, pp. 1041-6, 1996.
, “Eastern cooperative group trial of interferon gamma in metastatic melanoma: an innovative study design.”, Clin Cancer Res, vol. 2, no. 1, pp. 29-36, 1996.
, “Eastern Cooperative Group trial of interferon gamma in metastatic melanoma: An innovative study design,”, Clin Cancer Res, vol. 2, pp. 29-36, 1996.
, “[The effect of local control on overall survival after the breast-conserving therapy of breast carcinoma].”, Strahlenther Onkol, vol. 172, no. 4, pp. 181-5, 1996.
, “The effects of treatment noncompliance on power in a 2 x 2 factorial design.”, J Biopharm Stat, vol. 6, no. 3, pp. 263-70, 1996.
, “The effects of treatment noncompliance on power in a 2x2 factorial design,”, J Biopharm Stat, vol. 6, pp. 263-70, 1996.
, “Epidemiology of AIDS dementia complex in Europe,”, J Acquir Immune Defic Syndr Hum Retrovirol, vol. 1, pp. 39-44, 1996.
, “Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group.”, J Acquir Immune Defic Syndr Hum Retrovirol, vol. 11, no. 1, pp. 39-44, 1996.
, , , “Factors that impact on the outcome of second renal transplants in children,”, Transplantation, vol. 15;62, pp. 606-11, 1996.
, “Factors that impact on the outcome of second renal transplants in children.”, Transplantation, vol. 62, no. 5, pp. 606-11, 1996.
, “Higher maintenance cyclosporine dose decreases the risk of graft failure in North American children: a report of the North American Pediatric Renal Transplant Cooperative Study.”, J Am Soc Nephrol, vol. 7, no. 4, pp. 550-5, 1996.
, “Higher maintenance cyclosporine dose decreases the risk of graft failure in North American children: A report of the North American Pediatric Renal Transplant Cooperative Study,”, J Am Soc Nephrol, vol. 7, pp. 550-55, 1996.
, “How valid are clinical signs of dehydration in infants?,”, J Pediatr Gastroenterol Nutr, vol. 22, pp. 56-62, 1996.
, “How valid are clinical signs of dehydration in infants?”, J Pediatr Gastroenterol Nutr, vol. 22, no. 1, pp. 56-61, 1996.
, “Hydroxyurea [in the treatment of sickle cell anemia],”, American Hospital Formulary Service Drug Information, pp. 692-696, 1996.
,